China CDE Approved First Universal CAR-T IND !

/PRNewswire/ -- On March 17, 2022, China National Drug Administration Drug Review Center (CDE) approved first Universal Chemeric Antigen Receptor T (UCAR-T)...

Related Keywords

China ,Decheng ,Guangdong ,Nanjing ,Jiangsu , ,Immunotherapy Excellence Center ,National Intellectual Property Management Enterprise ,China National Drug Administration Review Center ,Unicorn Enterprises ,Innovation Talents Program Of Jiangsu Province ,National Science ,Bioheng Biotech Co Ltd ,Hillhouse Venture Capital ,Decheng Capital ,Octagon Capital ,Jiangsu Province ,Nanjing High Level Entrepreneurial Talent Plan ,Nanjing Expert Studio ,Nanjing Bioheng Biotech Co ,Td ,